Paratek Pharmaceuticals, Inc. Human Resources Contracts & Agreements

66 Contracts & Agreements

Browse by Subcategory

Bonus & Incentive Agreements (13 contracts)
Change of Control Agreements (19)
Compensation Agreements (12)
Consulting Agreements (1)
Employment Agreements (10)
Non-Competition Agreements (1)
Separation Agreements (1)
Severance Agreements (9)

Recent Contracts

Non-Employee Director Compensation Policy (Filed With SEC on March 14, 2022)
Non-Employee Director Compensation Policy (Filed With SEC on March 29, 2021)
Non-Employee Director Compensation Policy (Filed With SEC on May 11, 2020)
Consulting Agreement dated March 15, 2019 between the Company and Douglas Pagn (Filed With SEC on March 18, 2019)
Form of Award Agreement under the Revenue Performance Incentive Plan (Filed With SEC on October 4, 2018)
Revenue Performance Incentive Plan (Filed With SEC on October 4, 2018)
Non-Employee Director Compensation Policy (Filed With SEC on March 6, 2018)
Form of Director Stock Option Grant Notice and Option Agreement under the 2015 Equity Incentive Plan (Filed With SEC on March 6, 2018)
Form of Director Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2015 Equity Incentive Plan (Filed With SEC on March 6, 2018)
Employment Agreement, as amended, by and between the Company and Adam Woodrow dated as of August 4, 2017 (Filed With SEC on November 8, 2017)
Employment Agreement, as amended, by and between the Company and Douglas W. Pagn dated as of August 4, 2017 (Filed With SEC on November 8, 2017)
Employment Agreement, as amended, by and between the Company and Evan Loh, M.D. dated as of August 4, 2017 (Filed With SEC on November 8, 2017)
Employment Agreement, as amended, by and between the Company and William M. Haskel dated as of August 4, 2017 (Filed With SEC on November 8, 2017)
Employment Agreement, as amended, by and between the Company and Michael F. Bigham dated as of August 4, 2017 (Filed With SEC on November 8, 2017)
Form of Leadership Team Restricted Stock Unit Grant Notice and Form of Leadership Team Restricted Stock Unit Award Agreement under the Paratek Pharmaceuticals, Inc. 2015 Equity... (Filed With SEC on August 4, 2017)
Employment Agreement, as amended, by and between the Company and Adam Woodrow dated as of June 16, 2017 (Filed With SEC on August 2, 2017)
Employment Agreement, as amended, by and between the Company and Douglas W. Pagn dated as of June 16, 2017 (Filed With SEC on August 2, 2017)
Employment Agreement, as amended, by and between the Company and Evan Loh, M.D. dated as of June 16, 2017 (Filed With SEC on August 2, 2017)
Employment Agreement, as amended, by and between the Company and William M. Haskel dated as of June 16, 2017 (Filed With SEC on August 2, 2017)
Employment Agreement, as amended, by and between the Company and Michael F. Bigham dated as of June 16, 2017 (Filed With SEC on August 2, 2017)
PARATEK PHARMACEUTICALS, INC. ANNUAL INCENTIVE PLAN (Filed With SEC on June 16, 2017)
PARATEK PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 2, 2017)
Paratek Pharmaceuticals, Inc. Director Stock Option Grant Notice (2015 Equity Incentive Plan) (Filed With SEC on March 2, 2017)
Paratek Pharmaceuticals, Inc. Director Restricted Stock Unit Grant Notice (2015 Equity Incentive Plan) (Filed With SEC on March 2, 2017)
Paratek Pharmaceuticals, Inc. Leadership Team Restricted Stock Unit Grant Notice (2015 Equity Incentive Plan) (Filed With SEC on February 8, 2017)
PARATEK PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 9, 2016)
PARATEK PHARMACEUTICALS, INC. (FORMERLY KNOWN AS TRANSCEPT PHARMACEUTICALS, INC. 2006 INCENTIVE AWARD PLAN Amended and Restated Effective as of the Date of the 2010 Annual... (Filed With SEC on March 9, 2016)
Amended and Restated Non-Employee Director Cash Compensation Policy Effective as of January 1, 2015 (Filed With SEC on August 11, 2015)
Exhibit A EMPLOYEE PROPRIETARY INFORMATION, INVENTIONS ASSIGNMENT, NON- COMPETITION ANDNON-SOLICITATION AGREEMENT Exhibit A EMPLOYEE PROPRIETARY INFORMATION, INVENTIONS... (Filed With SEC on April 2, 2015)
PARATEK PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT AWARD GRANT NOTICE 2006 INCENTIVE AWARD PLAN (Filed With SEC on February 10, 2015)
AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (Filed With SEC on March 14, 2014)
AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (Filed With SEC on March 14, 2014)
AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (Filed With SEC on November 7, 2013)
AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (Filed With SEC on November 7, 2013)
AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (Filed With SEC on November 7, 2013)
AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (Filed With SEC on November 7, 2013)
AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (Filed With SEC on November 7, 2013)
TRANSCEPT PHARMACEUTICALS, INC. Fourth Amended and Restated Independent Director Equity Compensation Policy Effective April 10, 2013 (Filed With SEC on May 9, 2013)
TRANSCEPT PHARMACEUTICALS, INC. Third Amended and Restated Independent Director Equity Compensation Policy Effective January 4, 2013 (Filed With SEC on March 12, 2013)
CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (Filed With SEC on June 26, 2012)